Israeli drug company Teva reaches $4.3 billion settlement in US opioid lawsuits | The Times of Israel
These Israeli pharmaceutical stocks are down in the wake of Hamas attack - MarketWatch
Teva Pharmaceuticals is found liable in the opioid crisis : NPR
Teva reaches proposed $4.35 billion settlement of US opioid lawsuits | CNN Business
Israeli Pension Fund Manager Leads Class Action Against Teva Pharmaceuticals Over Price-Hike and Opioid Scandals | Courthouse News Service
Israel-based Teva settles opioid lawsuit with San Francisco for $45M
Israel Not Aiming to Punish Teva on Job Cuts, Official Says - Bloomberg
An Israeli pharma champion sickens
A Drug Company Wagers the U.S. Won't Dare Charge It With Crimes - The New York Times
Teva Pharmaceuticals at heart of major price fixing suit in US – www.israelhayom.com
Teva buys Allergan generic drug company for $40.5B - CBS News
Teva Pharmaceuticals: Israeli drugmaker to cut 14,000 jobs
Teva Restructuring Coming Together, Rebuilding Confidence in the Company | BioSpace
Teva Pharmaceuticals - Wikipedia
Teva Eyes 25 Percent of the $750 Million EpiPen Market by Year's End | BioSpace
Opioid Manufacturer Teva Pharmaceuticals Reaches $4B Global Settlement | Law.com
San Francisco reaches $58m opioid settlement with Teva, Allergan | Drugs News | Al Jazeera
Teva Pharmaceutical to Cut 14,000 Jobs - WSJ
Teva Lifts Outlook With Drug Production Mostly Unaffected by War - Bloomberg
Teva Pharmaceutical to Nominate Four New Directors - WSJ
Teva to pay $225 million to settle cholesterol drug price-fixing charges | The Times of Israel
Teva Pharmaceuticals found liable for role in New York opioid epidemic - UPI.com
Teva Faces New Class Action—But Could It Afford Another Settlement? | Connecticut Law Tribune
Israel's Teva to move US HQ from Pennsylvania to New Jersey | The Times of Israel
